ANXA2 and hepatocellular carcinoma: With the upregulation of ANXA2, the potential ability of metastatic and invasive is increased in hepatoma cell, shRNA-mediated ANXA2 silencing significantly inhibits cell invasion, migration, and tumorigenic potential [24].